首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Optically active 1,3,4,4-tetrasubstituted beta-lactams: synthesis and evaluation as tumor cell growth inhibitors.
【24h】

Optically active 1,3,4,4-tetrasubstituted beta-lactams: synthesis and evaluation as tumor cell growth inhibitors.

机译:光学活性的1,3,4,4-四取代的β-内酰胺类化合物:作为肿瘤细胞生长抑制剂的合成和评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The in vitro cytotoxicity assays of several enantiopure (3S,4S)- and (3R,4R)-1,3,4,4-tetrasubstituted beta-lactams derived from amino acids have shown that the (3S,4S)-4-benzyl-1-p-methoxybenzyl-3-methyl-4-methoxycarbonyl derivative 2a, obtained from Phe, displays significant activity, which is comparable to that of the anticancer drug Doxorubicin against HT29 cell lines. Modifications at positions 1 and 4 of the beta-lactam ring led to identify the Tyr(2,6-ClBz) analogu 26d with similar activity data to those of 2a. The synthesis and SAR of all these tetrasubstituted beta-lactams are reported here.
机译:几种源自氨基酸的对映体(3S,4S)-和(3R,4R)-1,3,4,4-四取代的β-内酰胺的体外细胞毒性试验表明,(3S,4S)-4-苄基从Phe获得的-1-对甲氧基苄基-3-甲基-4-甲氧基羰基衍生物2a显示出显着的活性,这与抗癌药物阿霉素对HT29细胞系的活性相当。 β-内酰胺环的位置1和4的修饰导致鉴定出具有与2a类似的活性数据的Tyr(2,6-ClBz)类似物26d。本文报道了所有这些四取代的β-内酰胺的合成和SAR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号